CLINICAL_TRIALS ClinicalTrials.gov record update

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04267848
Title field or adapter rule: {'original_value': 'Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:28.267187+00:00
Published At: 2026-10-30T00:00:00+00:00
Record Updated At: 2026-10-30
Source Retrieved At: 2026-10-31T22:18:03.495925+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Lung Non-Small Cell Carcinoma", "Lung Non-Small Cell Squamous Carcinoma", "Lung Non-Squamous Non-Small Cell Carcinoma", "Stage II Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-30", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT04267848"
protocolSection.identificationModule.officialTitle: "Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

Study condition terms

Interventions recorded in this study

{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Undergo blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Given IV', 'name': 'Carboplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Given IV', 'name': 'Cisplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Undergo CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Undergo ECHO', 'name': 'Echocardiography Test', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Given IV', 'name': 'Gemcitabine Hydrochloride', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)'], 'description': 'Undergo observation', 'name': 'Observation Activity', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Given IV', 'name': 'Paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Given IV', 'name': 'Pembrolizumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Given IV', 'name': 'Pemetrexed Disodium', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (platinum doublet, observation)', 'Arm B (platinum doublet, sequential pembrolizumab)', 'Arm C (platinum doublet, combination pembrolizumab)'], 'description': 'Ancillary studies', 'name': 'Questionnaire Administration', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.